ZURA
Zura Bio Limited Class A Ordinary Shares
NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY
$5.08
+1.40% today
Updated 2026-04-30
Market cap
$502.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$1 – $7
Volume
0.6M
Zura Bio Limited Class A Ordinary Shares (ZURA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-1.10M | $-1.20M | $-15.05M | $-28.08M | $-64.81M |
| Capital expenditures | $4.00 | $12.00M | $8.00M | $75000.00 | $113000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $334000.00 | $9.65M | $16.80M | $12.33M |
| Free cash flow | $-1.10M | $-13.20M | $-23.05M | $-28.15M | $-64.93M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |